about
Trigonal and peritrigonal lesions of the lateral ventricle-surgical considerations and outcome analysis of 20 patients.Non-aneurysmal non-traumatic subarachnoid hemorrhage: patient characteristics, clinical outcome and prognostic factors based on a single-center experience in 125 patients.Posterior communicating artery aneurysm-related oculomotor nerve palsy: influence of surgical and endovascular treatment on recovery: single-center series and systematic review.Decompressive craniectomy in children: single-center series and systematic review.Oculomotor nerve palsy by posterior communicating artery aneurysms: influence of surgical strategy on recovery.Aneurysm-related subarachnoid hemorrhage and acute subdural hematoma: single-center series and systematic review.Rat cisterna magna double-injection model of subarachnoid hemorrhage - background, advantages/limitations, technical considerations, modifications, and outcome measures.Endovascular and surgical treatment of internal carotid bifurcation aneurysms: comparison of results, outcome, and mid-term follow-up.Surgical Treatment of Spinal Dural Arteriovenous Fistula: Management and Long-Term Outcome in a Single-Center Series.Bone flap resorption: risk factors for the development of a long-term complication following cranioplasty after decompressive craniectomy.Cranioplasty after decompressive craniectomy: the effect of timing on postoperative complications.Beyond delayed cerebral vasospasm: infarct patterns in patients with subarachnoid hemorrhage.Clinical outcome and prognostic factors of patients with angiogram-negative and non-perimesencephalic subarachnoid hemorrhage: benign prognosis like perimesencephalic SAH or same risk as aneurysmal SAH?Metabolic changes in patients with aneurysmal subarachnoid hemorrhage apart from perfusion deficits: neuronal mitochondrial injury?Glioblastoma therapy in the elderly and the importance of the extent of resection regardless of age.Unsecured intracranial aneurysms and induced hypertension in cerebral vasospasm: is induced hypertension safe?Antiplatelet therapy, but not intravenous thrombolytic therapy, is associated with postoperative bleeding complications after decompressive craniectomy for stroke.Histological evidence of delayed ischemic brain tissue damage in the rat double-hemorrhage model.The impact of the body mass index on outcome after subarachnoid hemorrhage: is there an obesity paradox in SAH? A retrospective analysis.Erythropoietin neuroprotection is enhanced by direct cortical application following subdural blood evacuation in a rat model of acute subdural hematoma.Frequency, risk of hemorrhage and treatment considerations for cerebral arteriovenous malformations with associated aneurysms.Chronic subdural haematoma in elderly patients: a retrospective analysis of 322 patients between the ages of 65-94 years.Functional effects of levosimendan in rat basilar arteries in vitro.Experimental subarachnoid hemorrhage: double cisterna magna injection rat model--assessment of delayed pathological effects of cerebral vasospasm.Partial Response of Intractable Cluster-Tic Syndrome Treated by Cervical Non-Invasive Vagal Nerve Stimulation (nVNS).Decompressive hemicraniectomy in subarachnoid haemorrhage: the influence of infarction, haemorrhage and brain swelling.Decompressive craniectomy in subarachnoid hemorrhage.The effect of common carotid artery occlusion on delayed brain tissue damage in the rat double subarachnoid hemorrhage model.Natural history of small unruptured anterior circulation aneurysms: a prospective cohort study.Subarachnoid hemorrhage and intracerebral hematoma: incidence, prognostic factors, and outcomeLong-term effects of antiplatelet drugs on aneurysm occlusion after endovascular treatmentSubarachnoid hemorrhage and intracerebral hematoma caused by aneurysms of the anterior circulation: influence of hematoma localization on outcome
P50
Q33612420-2093A696-7460-42C0-AF21-EC6B9124106AQ33870036-DE5EBED2-6D05-4D13-BABA-EAC058787507Q37839664-833540BD-1B1F-4110-B2B1-274AE8E3E6A5Q37938582-21741BE1-E51F-4F7A-9D46-E707D408AEF7Q38039474-1BA7DFC8-7FC1-4299-9C4C-194927814B70Q38071689-2E06BCED-8CF3-420F-8622-70235D17E7F2Q38264710-F6251989-BF76-427E-ACF8-86590DB690A8Q38337663-87B4DE60-6988-48A3-8C0C-43D3664E66B6Q38366768-73867039-9F51-4EA8-BC63-4FB616A4F4BFQ39554121-CF095C35-5BC1-40BA-858E-23250ACB6908Q39671792-237972C6-EF85-4CF2-8202-60A207C3E221Q40064869-AF03F4BC-CD91-4825-B7CB-1AD84E49EDAAQ40219518-DC2B0467-2C84-452F-9E5A-D5EF2AC260CFQ43602363-C4BAB202-7749-4EE2-AEB4-7A2DDC456845Q43982278-44C58D29-0C5B-4599-ACF7-439E6F480C26Q43986518-569E6E0A-2E9F-4714-9B46-959E2A97400EQ44781877-6EF1FCBC-EB6C-4870-8F63-CB665F3AD445Q45325479-53B7B97F-2061-47D0-BEE9-6C08C60AC157Q45327413-C97D5315-139D-40BF-BD99-DAB0666A2DDCQ46205040-A6133F6A-2BEF-42F9-BEC9-0ED6E60FAE53Q46313510-CF43BC08-47E4-4CFA-8A2B-40709A3CDF4EQ46734343-3D833900-8408-45FF-9B1D-40C59BD1B922Q48135430-C9C09F04-EF0B-4683-8CFB-408205CCDCFAQ48316148-4441F0E6-BCCA-4284-9C1B-0E28AC87CEDBQ48339702-5DDCE94C-F2D0-4136-BAEE-D546FF74C76FQ48567780-4EEEAE7A-77E3-47AC-890A-7D2FB1F6B8D1Q48591805-11B2944F-18F4-4232-B3A0-26FD251B3F3EQ48852419-7158625F-689D-48F0-A454-8B5911D0587CQ51224084-7E4CF629-8BB2-4B5C-AE7A-4114E43694F3Q82842200-4D13AA20-9A4B-4549-8D02-673123F34CCBQ85078276-7F853DD5-523A-4393-AABC-1789A4C84091Q87380218-1B286E8B-7159-4DF3-9F13-101FBC4E63DD
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Erdem Güresir
@en
Erdem Güresir
@nl
type
label
Erdem Güresir
@en
Erdem Güresir
@nl
prefLabel
Erdem Güresir
@en
Erdem Güresir
@nl
P31
P496
0000-0001-8319-0847